SPECT in asymptomatic diabetics with and without microalbuminuria

Area of Science:

• Cardiology
• Diabetology
• Nuclear Medicine

Background:

• Coronary artery disease (CAD) is a significant concern in patients with type 2 diabetes mellitus.
• Asymptomatic diabetics often have underlying CAD, necessitating effective screening methods.
• Microalbuminuria is recognized as a marker for cardiovascular risk in diabetic populations.

Purpose of the Study:

• To evaluate myocardial perfusion single photon emission computed tomography (MPS) for detecting CAD in asymptomatic diabetics.
• To assess the correlation between microalbuminuria and the presence of CAD in this patient group.
• To compare MPS findings with coronary angiography.

Main Methods:

• Ninety-nine asymptomatic diabetic patients (age 30-80) with CAD risk factors were enrolled.
• Patients were categorized into microalbuminuria-positive (Micral+, n=38) and microalbuminuria-negative (Micral-, n=61) groups.
• Ischemia was assessed using MPS and findings were correlated with coronary angiographic (CAG) results.

Main Results:

• MPS identified CAD in 39 out of 99 patients.
• Of those with positive MPS, 79.5% were Micral positive.
• Micral-positive patients with positive MPS showed a high prevalence of multivessel CAD on angiography, with MPS demonstrating 91.4% sensitivity and 74.1% specificity for significant CAD detection.

Conclusions:

• Microalbuminuria is a valuable and cost-effective screening tool predicting major cardiovascular events in type 2 diabetes.
• MPS is a sensitive and non-invasive diagnostic test for identifying CAD in asymptomatic diabetic patients.
• The combination of microalbuminuria and MPS can aid in risk stratification and early diagnosis of CAD.